Abstract
A 64-year-old man was diagnosed with cholangiocellular carcinoma based on preoperative computed tomography and magnetic resonance imaging and underwent laparoscopic segmentectomy (Segment 8) of the liver for radical operation. Pathological examination revealed the presence of an undifferentiated carcinoma with osteoclast-like giant cells, which were categorized as T3N0M0 and Stage III based on the third English edition of the Japanese classification of liver cancer. The patient was treated with three courses of combination chemotherapy, which included gemcitabine (1000 mg/m2) and cisplatin (25 mg/m2), as well as S-1 (120 mg/day) for adjuvant chemotherapy. At two months after the operation, CT revealed multiple liver- and lung metastases. Thereafter, the patient was prescribed the molecularly targeted drug, lenvatinib (12 mg/day). However, lenvatinib was not effective, as evident by the extension of several metastases. Testing for microsatellite instability was negative. The patient died 5 months after the operation. We experienced a case of primary undifferentiated carcinoma with osteoclast-like giant cells in the liver showed rapidly developing multiple metastases after curative liver resection.
Similar content being viewed by others
References
Nakasuka H, Okada S, Okusaka T et al (1998) Undifferentiated carcinoma of the liver with neuroendocrine features: a case report. Jpn J Clin Oncol 28:401–404
Hiraki M, Kitahara K, Miyoshi A et al (2018) A long-term survivor of undifferentiated carcinoma of the liver successfully treated with surgical treatments: a case report and literature review. Int J Surg Case Rep 51:45–49
Maeda T, Kayashima H, Imai D et al (2017) Undifferentiated carcinoma of the liver: a case report with immunohistochemical analysis. Surg Case Rep 3:12
Kubo M, Kitano M, Sakurai T et al (2015) General rules for the clinical and pathological study of primary liver cancer. Nationwide follow-up survey and clinical practice guidelines: the outstanding achievements of the liver cancer study group of Japan. Dig Dis 33:765–770
Bosman FT, Cameiro F, Hruban RH et al (2010) WHO classification of tumours of the digestive system, vol 3, 4th edn. International Agency for Research on Cancer, Lyon
Ananthakrishnan A, Gogineni V, Saeian K (2006) Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol 23:47–63
Livraghi T, Mäksalo H, Line PD (2011) Treatment options in hepatocellular carcinoma today. Scand J Surg 100:22–29
Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314
Villanueva A (2019) Hepatocellular carcinoma. N Engl J Med 381:e2
Munoz PA, Rao MS, Reddy JK (1980) Osteoclastoma-like giant cell tumor of the liver. Cancer 46:771–779
Andreola S, Lombardi L, Scurelli A et al (1985) Osteoclastoma-like giant-cell tumor of the liver. Case Rep Tumori 71:615–620
Horie Y, Hori T, Hirayama C et al (1987) Osteoclast-like giant cell tumor of the liver. Acta Pathol Jpn 37:1327–1335
McCluggage WG, Toner PG (1993) Hepatocellular carcinoma with osteoclast-like giant cells. Histopathology 23:187–189
Sasaki A, Yokoyama S, Nakayama I et al (1997) Sarcomatoid hepatocellular carcinoma with osteoclast-like giant cells: case report and immunohistochemical observations. Pathol Int 47:318–324
Ahaouche M, Cazals-Hatem D, Sommacale D et al (2005) A malignant hepatic tumour with osteoclast-like giant cells. Histopathology 46:590–592
Rudloff U, Gao ZQ, Fields S et al (2005) Osteoclast-like giant cell tumor of the liver: a rare neoplasm with an aggressive clinical course. J Gastrointest Surg 9:207–214
Shimizu Y, Kaneko F, Motoori T et al (2011) Undifferentiated hepatocellular carcinoma difficult to distinguish from liver abscess. Intern Med 50:519–520
Matsumoto R, Yoshida K, Nakajima J et al (2012) Osteoclast-like giant cell tumor (OGCT) of the liver: report of a case [in Japanese]. Nihon Shokakibyo Gakkai Zasshi 109:255–262
Dahm HH (2015) Immunohistochemical evaluation of a sarcomatoid hepatocellular carcinoma with osteoclast like giant cells. Diagn Pathol 10:40
Chan Wah Hak C, Coyle C, Kocache A et al (2019) Emergency etoposide-cisplatin (Em-EP) for patients with germ cell tumours (GCT) and trophoblastic neoplasia (TN). BMC Cancer 19:770
Bosl GJ, Yagoda A, Whitmore WF Jr et al (1984) VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors. Am J Clin Oncol 7:327–330
Peckham MJ, Barrett A, Liew KH et al (1983) The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cisplatin (BEP). Br J Cancer 47:613–619
Janowitz T, Welsh S, Warren AY et al (2015) Prostatic elapse of an undifferentiated teratoma 24 years after orchidectomy. BMC Res Notes 8:524
Arndt CA, Nascimento AG, Schroeder G et al (1998) Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide. Eur J Cancer 34:1224–1229
Yazawa T, Watanabe A, Araki K et al (2017) Complete resection of a huge pancreatic undifferentiated carcinoma with osteoclast-like giant cell. Int Cancer Conf J 6:193–196
Singhi AD, Seethala RR, Nason K et al (2015) Undifferentiated carcinoma of the esophagus: a clinicopathological study of 16 cases. Hum Pathol 46:366–375
Tajima S, Waki M, Tsuchiya T et al (2014) Granulocyte colony-stimulating factor-producing undifferentiated carcinoma of the colon mimicking a pulmonary giant cell carcinoma: a case showing overexpression of CD44 along with highly proliferating nestin-positive tumor vessels. Int J Clin Exp Pathol 7:7034–7041
Acknowledgements
We gratefully acknowledge the contributions of past and present members of our division.
Author information
Authors and Affiliations
Contributions
NK conducted the literature search and review, collected data, and drafted the manuscript. TN and DH proofread the manuscript. TY and YM discussed the significance of this manuscript. MS reviewed the manuscript and provided advice regarding the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Informed consent
Written informed consent for publication of their clinical details and/or clinical images was obtained from the relative of the patient.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kamitani, N., Nomi, T., Hokuto, D. et al. Primary undifferentiated carcinoma with osteoclast-like giant cells in liver and rapidly developing multiple metastases after curative hepatectomy: a case report. Int Canc Conf J 9, 244–248 (2020). https://doi.org/10.1007/s13691-020-00436-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13691-020-00436-0